PAH
Clinical trials for PAH explained in plain language.
Never miss a new study
Get alerted when new PAH trials appear
Sign up with your email to follow new studies for PAH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for PAH patients: Long-Term drug safety trial opens
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of the drug ralinepag in people with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. About 1,000 adults who were in earlier ralinepag studies can join. The goal is to see if the drug remains s…
Matched conditions: PAH
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could a protein on blood vessel cells be key to treating a rare heart condition?
Knowledge-focused ENROLLING_BY_INVITATIONThis study investigates whether a drug called XBD173, which targets a protein (TSPO) on blood vessel lining cells, can help understand how these cells contribute to pulmonary artery hypertension (PAH). PAH is a rare condition where narrowed lung blood vessels strain the heart. Si…
Matched conditions: PAH
Phase: PHASE1 • Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC